Weed, Inc. (BUDZ): Total Assets
$559.9K
As of 2025-12-31
$504.0K
As of 2026-06-30
-30.0%
3-year compound annual growth
-21.0%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $559.9K | -24.2% | 2026-04-08, Balance as of period end |
| 2024-12-31 | $738.4K | -18.3% | 2026-04-08, Balance as of period end |
| 2023-12-31 | $904.1K | -44.7% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $1.63M | -16.6% | 2024-04-01, Balance as of period end |
| 2021-12-31 | $1.96M | +7.7% | 2023-03-31, Balance as of period end |
| 2020-12-31 | $1.82M | -6.8% | 2022-03-31, Balance as of period end |
| 2019-12-31 | $1.95M | -35.4% | 2021-03-31, Balance as of period end |
| 2018-12-31 | $3.02M | +130.9% | 2020-03-30, Balance as of period end |
| 2017-12-31 | $1.31M | n/a | 2019-04-16, Balance as of period end |
| No annual figure between 2011-12-31 and 2017-12-31. | |||
| 2011-12-31 | $132.3K | -27.8% | 2012-04-16, Balance as of period end |
| 2010-12-31 | $183.3K | n/a | 2012-04-16, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Weed, Inc. (BUDZ) | 2025-12-31 | $559.9K | -24.2% |
| NRC Health (NRC) | 2025-12-31 | $134.88M | +1.8% |
| Incyte Corp (INCY) | 2025-12-31 | $6.96B | +27.8% |
| Icon PLC (ICLR) | 2025-12-31 | $16.27B | -2.2% |
| Charles River Laboratories International, Inc. (CRL) | 2025-12-27 | $7.14B | -5.2% |
| MaxCyte, Inc. (MXCT) | 2025-12-31 | $202.51M | -15.4% |
| Cannabis Bioscience International Holdings, Inc. (CBIH) | 2025-05-31 | $31.9K | -44.2% |
| Iqvia Holdings Inc. (IQV) | 2025-12-31 | $29.94B | +11.3% |
| iSpecimen Inc. (ISPC) | 2025-12-31 | $9.53M | +1.9% |
Compare BUDZ, NRC, INCY, ICLR side by side · Screen every company in Services-Commercial Physical & Biological Research ↗